Drugs / Novolin-R insulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04115384 | Sep 2019 → Feb 2020 | behavioral variant of frontotemporal dementia | HealthPartners Institute | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Novolin-R insulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04115384 ↗ |
| Known as | insulin, Novolin-R | “insulin, Novolin-R” NCT04115384 ↗ |
| Route | Intranasal | “intranasal (IN) insulin” NCT04115384 ↗ |